SARL BIOTECH 3D : revenue, balance sheet and financial ratios

SARL BIOTECH 3D is a French company founded 15 years ago, specialized in the sector Commerce de gros (commerce interentreprises) d'autres produits intermédiaires. Based in LA MAXE (57140), this company of category PME shows in 2021 a revenue of 129 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL BIOTECH 3D (SIREN 523351088)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C 128 606 € 161 479 € 138 014 € 115 067 €
Net income 779 € 153 € 3 921 € 5 989 € 11 025 € 1 260 € 1 830 €
EBITDA N/C N/C N/C 5 630 € 23 504 € 1 494 € 1 966 €
Net margin N/C N/C N/C 4.7% 6.8% 0.9% 1.6%

Revenue and income statement

In 2024, SARL BIOTECH 3D generates positive net income of 779 €. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 2 k€ -> 779 €.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

779 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 36%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

35.743%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

61.408%

Solvency indicators evolution
SARL BIOTECH 3D

Sector positioning

Debt ratio
35.74 2024
2022
2023
2024
Q1: 0.14
Med: 12.14
Q3: 43.04
Average

In 2024, the debt ratio of SARL BIOTECH 3D (35.74) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
61.41% 2024
2022
2023
2024
Q1: 23.34%
Med: 47.87%
Q3: 67.91%
Good +23 pts over 3 years

In 2024, the financial autonomy of SARL BIOTECH 3D (61.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 589.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

589.375

Liquidity indicators evolution
SARL BIOTECH 3D

Sector positioning

Liquidity ratio
589.38 2024
2022
2023
2024
Q1: 162.26
Med: 245.95
Q3: 425.37
Excellent +23 pts over 3 years

In 2024, the liquidity ratio of SARL BIOTECH 3D (589.38) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1384 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 465 days. The gap of 919 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

1384 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

465 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL BIOTECH 3D

Positioning of SARL BIOTECH 3D in its sector

Comparison with sector Commerce de gros (commerce interentreprises) d'autres produits intermédiaires

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (39 transactions). This range of 327€ to 4 692€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
0k€ 1k€ 4k€
1 027 € Range: 327€ - 4 692€
NAF 5 all-time

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 39 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) d'autres produits intermédiaires)

Compare SARL BIOTECH 3D with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) d'autres produits intermédiaires

Frequently asked questions about SARL BIOTECH 3D

What is the revenue of SARL BIOTECH 3D ?

The revenue of SARL BIOTECH 3D in 2021 is 129 k€.

Is SARL BIOTECH 3D profitable?

Yes, SARL BIOTECH 3D generated a net profit of 779€ in 2024.

Where is the headquarters of SARL BIOTECH 3D ?

The headquarters of SARL BIOTECH 3D is located in LA MAXE (57140), in the department Moselle.

Where to find the tax return of SARL BIOTECH 3D ?

The tax return of SARL BIOTECH 3D is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL BIOTECH 3D operate?

SARL BIOTECH 3D operates in the sector Commerce de gros (commerce interentreprises) d'autres produits intermédiaires (NAF code 46.76Z). See the 'Sector positioning' section above to compare the company with its competitors.